Effect Of Curcumin As Coronary Heart Disease


  • Anggun Elidiya
  • Rizki Hanriko
  • M. Yusran




Coronary Heart Disease, curcumin, treatment


Atherosclerosis is a chronic and progressive problem due to the inflammatory response, oxidative stress (OS), lipid deregulation, and epigenetic disorders. Curcumin is the main compound in turmeric and is responsible for turmeric yellow and contains 50% of turmeric. Curcumin has a hypolipidemic effect along with antioxidant and anti-inflammatory, it can contribute to reduce the incidence of atherosclerosis. The extraordinary antioxidant content of curcumin reduces lipid peroxidation and oxLDL formation, and consequently, reduces the inflammatory response and the development of atherosclerosis. Another study shows that curcumin can alter gene expression associated with leukocyte adhesion and transendothelial migration in aortic tissue by increasing expression of NF-κB protein inhibitors (IκB) and decreasing NF-κB bonds and transcription activity after stimulation with tumor necrosis factor-α (TNF-α). In addition, it is proven that curcumin can regulate the activation of toll-like receptor 4 (TLR4), a receptor that recognizes exogenous or endogenous molecular patterns and modulates immune and inflammatory responses. The role of other curcumin for atherosclerosis is smooth muscle cell proliferation. Curcumin is an antioxidant that can be one of the management of coronary heart disease due to be able to suppress the formation of atherosclerosis and reduce cholesterol levels in the blood. It is expected that curcumin can be the first treatment for coronary heart disease.


Lichtenstein AH. Atherosclerosis. Dalam: Caballero B, ed. Encyclopedia of food sciences and nutrition. New York: Academic Press; 2003.

Kelley K, Kemple A, Rush C, Sarliker SE. Coronary heart disease. Washington: Washington State Department of Health; 2013.

Writing Group Members, Mozaffarian D, Benjamin EJ, et al. Executive Summary: Heart Disease and Stroke Statistics--2016 Update: A Report From the American Heart Association. Circulation. 2016;133:447-54.

Kementerian Kesehatan RI. Badan Penelitian dan Pengembangan Kesehatan. Riset Kesehatan Dasar 2013. Jakarta: Kementerian Kesehatan RI; 2013

Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Zannad F, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The fifth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012;33(13):1635-701.

Xu, Pelisek, Jin, G. Atherosclerosis is an epigenetic disease. Trends Endocrinol Metab. 2018; 29 (11), 739–742.

Libby, P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation. 2001; 104 (3):365–372.

Hansson, G.. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 2005; 352 (16), 1685–1695.

Zingg, Hasan, Meydani. Molecular mechanisms of hypolipidemic effects of curcumin. Biofactors. 2013; 39 (1), 101–121.

Kocaadam, Sanlier. Curcumin, an active component of turmeric (Curcuma longa), and its effects on health. Crit. Rev. Food Sci. Nutr.. 2017; 57 (13):2889–2895.

Akbik, Ghadiri, Chrzanowski, Rohanizadeh. Curcumin as a wound healing agent. Life Sci. 2014; 116 (1):1–7.

Chattopadhyay, I., Biswas, K., Bandyopadhyay, U., Banerjee, R.K., 2004. Turmeric and curcumin: biological actions and medicinal applications. Curr. Sci. 87 (1), 44–53.

Aggarwal, Harikumar. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int. J. Biochem. Cell Biol. 2009; 41 (1):40–59.

Prasad, Gupta, Tyagi, Aggarwal. Curcumin, a component of golden spice: from bedside to bench and back. Biotechnol. 2014; 32 (6):1053–1064.

Sharma, O. Antioxidant activity of curcumin and related compounds. Biochem. Pharmacol. 1976; 25 (15):1811–1812.

Karuppagounder, Arumugam, Giridharan, Sreedhar, Bose, Vanama et. al. Tiny molecule, big power: multi molecule, big power: multi-target approach for curcumin in diabetic cardiomyopathy. Nutrition. 2017; 34: 47–54.

Campbell, Fleenor. The emerging role of curcumin for improving vascular dysfunction: a review. Crit. Rev. Food Sci. Nutr. 2017;1(1):1–10.

Panahi, Ahmadi, Teymouri, Johnston, Sahebkar. Curcumin as a potential candidate for treating hyperlipidemia: a review of cellular and metabolic mechanisms. J. Cell. Physiol. 2018; 233 (1):141–152.

Olszanecki, Jawien, Gajda, Mateuszuk, Gebska, Korabiowska, et al. Effect of curcumin on atherosclerosis in apoE/LDLRdouble knockout mice. J. Physiol. Pharmacol. 2005; 56 (4):627–635.

Coban, Milenkovic, Chanet, Khallou-Laschet, Sabbe, Palagani, et al. Dietary curcumin inhibits atherosclerosis by affecting the expression of genes involved in leukocyte adhesion and transendothelial migration. Mol. Nutr. Food Res. 2012; 56 (8):1270–1281.

Zhang, Lin, Bao, Wu, Wang, Yang. Effects of curcumin on sarcoplasmic reticulum Ca2+-ATPase in rabbits with heart failure. Zhonghua xin xue guan bing za zhi. 2010; 38 (4):369–373.

Gao, Zhang, Zhao, Zhou, Wu, Liu, et. al. Curcumin ameliorates atherosclerosis in apolipoprotein E deficient asthmatic mice by regulating the balance of Th2/Treg cells. Phytomedicine. 2009; 52:129–135.

Tian, Ogura, Little, Xu, Sawamura. Targeting LOX-1 in atherosclerosis and vasculopathy: current knowledge and future perspectives. Ann. N. Y. Acad. Sci. 2018; 5(1):1-7.

Hasan, Zingg, Kwan, Noble, Smith, Meydani. Curcumi modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice. Atherosclerosis. 2014; 232 (1):40–51.

Liu, An, Yang, Xiao, Wang, Hu et. al.. Protection effect of curcumin for macrophage-involved polyethylene wear particle-induced inflammatory osteolysis by increasing the cholesterol efflux. Med. Sci. Monit. 2019;25:10–20.

Karimian, Pirro, Johnston, Majeed, Sahebkar. Curcumin and endothelial function: evidence and mechanisms of protective effects. Curr. Pharm. 2017; 23 (17):2462–2473.

Shi, Deng, Zhang. Curcumin pretreatment protects against PM2.5-induced oxidized lowdensity lipoproteinmediated oxidative stress and inflammation in human microvascular endothelial cells. Mol. Med. Rep. 2017;16(3):2588–2594.

Yang, Thomas, Zhang, Culver, Alexander, Murdoch et. al. Curcumin inhibits platelet-derived growth factor-stimulated vascular smooth muscle cell function and injury-induced neointima formation. Arterioscler. Thromb. Vasc. Biol. 2006; 26 (1), 85–90.

Yuan, Kuang, Zheng, Ling, Yang, Yan, et al. Curcumin inhibits cellular cholesterol accumulation by regulating SREBP-1/ caveolin-1 signaling pathway in vascular smooth muscle cells. Acta Pharmacol. Sin. 2008; 29(5):555–563

Pendyala, Walker, Holt. A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology. 2012; 142 (5):1100–1101 e1102.

Ghosh, Bie, Wang, Ghosh. Oral supplementation with non-absorbable antibiotics or curcumin attenuates western diet-induced atherosclerosis and glucose intolerance in LDLR−/− mice–role of intestinal permeability and macrophage activation. PLoS One. 2014; 9 (9):e108577.

Mahfous MM, Zhou SQ, Kummerow FA. Curcumin prevents the oxidation and lipid modification of LDL and its inhibition of prostacyclin generation by endothelial cells in culture. Prostaglandins Others Lipid Mediat. 2009;90(1-2):13-20.



How to Cite

Anggun Elidiya, Rizki Hanriko, & M. Yusran. (2019). Effect Of Curcumin As Coronary Heart Disease. Medical Profession Journal of Lampung, 9(2), 235-239. https://doi.org/10.53089/medula.v9i2.264




Most read articles by the same author(s)

1 2 > >>